Skip to main content
Top
Published in: Diabetologia 6/2006

01-06-2006 | Article

The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets

Authors: S. Zraika, K. Aston-Mourney, D. R. Laybutt, M. Kebede, M. E. Dunlop, J. Proietto, S. Andrikopoulos

Published in: Diabetologia | Issue 6/2006

Login to get access

Abstract

Aims/hypothesis

We determined whether high-glucose-induced beta cell dysfunction is associated with oxidative stress in the DBA/2 mouse, a mouse strain susceptible to islet failure.

Materials and methods

Glucose- and non-glucose-mediated insulin secretion from the islets of DBA/2 and control C57BL/6 mice was determined following a 48-h exposure to high glucose. Flux via the hexosamine biosynthesis pathway was assessed by determining O-glycosylated protein levels. Oxidative stress was determined by measuring hydrogen peroxide levels and the expression of anti-oxidant enzymes.

Results

Exposure to high glucose levels impaired glucose-stimulated insulin secretion in DBA/2 islets but not C57BL/6 islets, and this was associated with reduced islet insulin content and lower ATP levels than in C57BL/6 islets. Exposure of islets to glucosamine for 48 h mimicked the effects of high glucose on insulin secretion in the DBA/2 islets. High glucose exposure elevated O-glycosylated proteins; however, this occurred in islets from both strains, excluding a role for O-glycosylation in the impairment of DBA/2 insulin secretion. Additionally, both glucosamine and high glucose caused an increase in hydrogen peroxide in DBA/2 islets but not in C57BL/6 islets, an effect prevented by the antioxidant N-acetyl-l-cysteine. Interestingly, while glutathione peroxidase and catalase expression was comparable between the two strains, the antioxidant enzyme manganese superoxide dismutase, which converts superoxide to hydrogen peroxide, was increased in DBA/2 islets, possibly explaining the increase in hydrogen peroxide levels.

Conclusions/interpretation

Chronic high glucose culture caused an impairment in glucose-stimulated insulin secretion in DBA/2 islets, which have a genetic predisposition to failure, and this may be the result of oxidative stress.
Literature
1.
go back to reference Flatt P, Barnett C, Swanston-Flatt S (1994) Mechanisms of pancreatic B-cell dysfunction and glucose toxicity in non-insulin dependent diabetes. Biochem Soc Trans 22:18–23PubMed Flatt P, Barnett C, Swanston-Flatt S (1994) Mechanisms of pancreatic B-cell dysfunction and glucose toxicity in non-insulin dependent diabetes. Biochem Soc Trans 22:18–23PubMed
2.
go back to reference Leahy J, Bonner-Weir S, Weir G (1992) Beta-cell dysfunction induced by chronic hyperglycaemia: current ideas on the mechanism of the impaired glucose-induced insulin secretion. Diabetes Care 15:442–455PubMedCrossRef Leahy J, Bonner-Weir S, Weir G (1992) Beta-cell dysfunction induced by chronic hyperglycaemia: current ideas on the mechanism of the impaired glucose-induced insulin secretion. Diabetes Care 15:442–455PubMedCrossRef
4.
go back to reference Sako Y, Grill V (1990) Coupling of beta-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes 39:1580–1583PubMedCrossRef Sako Y, Grill V (1990) Coupling of beta-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes 39:1580–1583PubMedCrossRef
5.
go back to reference Kaiser N, Corcos A, Sarel I, Cerasi E (1991) Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose. Endocrinology 129:2067–2076PubMedCrossRef Kaiser N, Corcos A, Sarel I, Cerasi E (1991) Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose. Endocrinology 129:2067–2076PubMedCrossRef
6.
go back to reference Eizirik D, Korbutt S, Hellerstrom C (1992) Prolonged exposure of human islets to high glucose concentrations in vitro impairs the B-cell function. J Clin Invest 90:1263–1268PubMedCrossRef Eizirik D, Korbutt S, Hellerstrom C (1992) Prolonged exposure of human islets to high glucose concentrations in vitro impairs the B-cell function. J Clin Invest 90:1263–1268PubMedCrossRef
7.
go back to reference Poitout V, Olson LK, Robertson RP (1996) Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Invest 97:1041–1046PubMedCrossRef Poitout V, Olson LK, Robertson RP (1996) Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Invest 97:1041–1046PubMedCrossRef
8.
go back to reference Robertson R, Zhang H-J, Ryzdrowski K, Walseth T (1992) Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 90:320–325PubMedCrossRef Robertson R, Zhang H-J, Ryzdrowski K, Walseth T (1992) Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 90:320–325PubMedCrossRef
9.
go back to reference Kajimoto Y, Matsuoka T, Kaneto H et al (1999) Induction of glycation suppresses glucokinase gene expression in HIT-T15 cells. Diabetologia 42:1417–1424PubMedCrossRef Kajimoto Y, Matsuoka T, Kaneto H et al (1999) Induction of glycation suppresses glucokinase gene expression in HIT-T15 cells. Diabetologia 42:1417–1424PubMedCrossRef
10.
go back to reference Kooptiwut S, Kebede M, Zraika S et al (2005) High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. J Mol Endocrinol 35:39–48PubMedCrossRef Kooptiwut S, Kebede M, Zraika S et al (2005) High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. J Mol Endocrinol 35:39–48PubMedCrossRef
11.
go back to reference Hribal ML, Perego L, Lovari S et al (2003) Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans. Faseb J 17:1340–1342PubMed Hribal ML, Perego L, Lovari S et al (2003) Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans. Faseb J 17:1340–1342PubMed
12.
go back to reference Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H (2003) Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581–587PubMedCrossRef Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H (2003) Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581–587PubMedCrossRef
13.
go back to reference Lenzen S, Drinkgern J, Tiedge M (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20:463–466PubMedCrossRef Lenzen S, Drinkgern J, Tiedge M (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20:463–466PubMedCrossRef
14.
go back to reference Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790PubMedCrossRef Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790PubMedCrossRef
15.
go back to reference Robertson RP, Harmon J, Tran PO, Poitout V (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53(Suppl 1):S119–S124PubMedCrossRef Robertson RP, Harmon J, Tran PO, Poitout V (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53(Suppl 1):S119–S124PubMedCrossRef
16.
go back to reference Del Guerra S, Lupi R, Marselli L et al (2005) Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54:727–735PubMedCrossRef Del Guerra S, Lupi R, Marselli L et al (2005) Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54:727–735PubMedCrossRef
17.
go back to reference Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412PubMedCrossRef Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412PubMedCrossRef
18.
go back to reference Hunt JV, Dean RT, Wolff SP (1988) Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256:205–212PubMed Hunt JV, Dean RT, Wolff SP (1988) Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256:205–212PubMed
19.
go back to reference Tanaka Y, Tran PO, Harmon J, Robertson RP (2002) A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci USA 99:12363–12368PubMedCrossRef Tanaka Y, Tran PO, Harmon J, Robertson RP (2002) A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci USA 99:12363–12368PubMedCrossRef
20.
go back to reference Wu L, Nicholson W, Knobel SM et al (2004) Oxidative stress is a mediator of glucose toxicity in insulin-secreting pancreatic islet cell lines. J Biol Chem 279:12126–12134PubMedCrossRef Wu L, Nicholson W, Knobel SM et al (2004) Oxidative stress is a mediator of glucose toxicity in insulin-secreting pancreatic islet cell lines. J Biol Chem 279:12126–12134PubMedCrossRef
21.
go back to reference Kaneto H, Xu G, Song KH et al (2001) Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J Biol Chem 276:31099–31104PubMedCrossRef Kaneto H, Xu G, Song KH et al (2001) Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J Biol Chem 276:31099–31104PubMedCrossRef
22.
go back to reference Zraika S, Dunlop M, Proietto J, Andrikopoulos S (2002) The hexosamine biosynthesis pathway regulates insulin secretion via protein glycosylation in mouse islets. Arch Biochem Biophys 405:275–279PubMedCrossRef Zraika S, Dunlop M, Proietto J, Andrikopoulos S (2002) The hexosamine biosynthesis pathway regulates insulin secretion via protein glycosylation in mouse islets. Arch Biochem Biophys 405:275–279PubMedCrossRef
23.
go back to reference Molina JM, Premdas FH, Klenck RE, Eddlestone G, Oldham SB, Lipson LG (1984) The dynamic insulin secretory response of isolated pancreatic islets of the diabetic mouse. Evidence for a gene dosage effect on insulin secretion. Diabetes 33:1120–1123PubMedCrossRef Molina JM, Premdas FH, Klenck RE, Eddlestone G, Oldham SB, Lipson LG (1984) The dynamic insulin secretory response of isolated pancreatic islets of the diabetic mouse. Evidence for a gene dosage effect on insulin secretion. Diabetes 33:1120–1123PubMedCrossRef
24.
go back to reference Leiter E, Coleman D, Hummel K (1981) The influence of genetic background on the expression of mutations at the diabetes locus in the mouse: effect of H-2 haplotype and sex. Diabetes 30:1029–1034PubMedCrossRef Leiter E, Coleman D, Hummel K (1981) The influence of genetic background on the expression of mutations at the diabetes locus in the mouse: effect of H-2 haplotype and sex. Diabetes 30:1029–1034PubMedCrossRef
25.
go back to reference Kooptiwut S, Zraika S, Thorburn AW et al (2002) Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure. Endocrinology 143:2085–2092PubMedCrossRef Kooptiwut S, Zraika S, Thorburn AW et al (2002) Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure. Endocrinology 143:2085–2092PubMedCrossRef
26.
go back to reference Gembal M, Detimary P, Gilon P, Gao Z-Y, Henquin J (1993) Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B-cells. J Clin Invest 91:871–880PubMedCrossRef Gembal M, Detimary P, Gilon P, Gao Z-Y, Henquin J (1993) Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B-cells. J Clin Invest 91:871–880PubMedCrossRef
27.
go back to reference Zraika S, Dunlop ME, Proietto J, Andrikopoulos S (2004) Elevated SNAP-25 is associated with fatty acid-induced impairment of mouse islet function. Biochem Biophys Res Commun 317:472–477PubMedCrossRef Zraika S, Dunlop ME, Proietto J, Andrikopoulos S (2004) Elevated SNAP-25 is associated with fatty acid-induced impairment of mouse islet function. Biochem Biophys Res Commun 317:472–477PubMedCrossRef
28.
go back to reference Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedCrossRef Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedCrossRef
29.
go back to reference Hodarnau A, Dancea S, Barzu O (1973) Isolation of highly purified mitochondria from rat pancreas. J Cell Biol 59:222–227PubMedCrossRef Hodarnau A, Dancea S, Barzu O (1973) Isolation of highly purified mitochondria from rat pancreas. J Cell Biol 59:222–227PubMedCrossRef
30.
go back to reference Kooptiwut S, Zraika S, Thorburn AW et al (2002) Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure. Endocrinology 143:2085–2092PubMedCrossRef Kooptiwut S, Zraika S, Thorburn AW et al (2002) Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure. Endocrinology 143:2085–2092PubMedCrossRef
31.
go back to reference Konrad RJ, Tolar JF, Hale JE, Knierman MD, Becker GW, Kudlow JE (2001) Purification of the O-glycosylated protein p135 and identification as O-GlcNAc transferase. Biochem Biophys Res Commun 288:1136–1140PubMedCrossRef Konrad RJ, Tolar JF, Hale JE, Knierman MD, Becker GW, Kudlow JE (2001) Purification of the O-glycosylated protein p135 and identification as O-GlcNAc transferase. Biochem Biophys Res Commun 288:1136–1140PubMedCrossRef
32.
go back to reference Pehuet-Figoni M, Ballot E, Bach JF, Chatenoud L (1994) Aberrant function and long-term survival of mouse beta cells exposed in vitro to high glucose concentrations. Cell Transplant 3:445–451PubMed Pehuet-Figoni M, Ballot E, Bach JF, Chatenoud L (1994) Aberrant function and long-term survival of mouse beta cells exposed in vitro to high glucose concentrations. Cell Transplant 3:445–451PubMed
33.
go back to reference Gapp DA, Leiter EH, Coleman DL, Schwizer RW (1983) Temporal changes in pancreatic islet composition in C57BL/6J-db/db (diabetes) mice. Diabetologia 25:439–443PubMedCrossRef Gapp DA, Leiter EH, Coleman DL, Schwizer RW (1983) Temporal changes in pancreatic islet composition in C57BL/6J-db/db (diabetes) mice. Diabetologia 25:439–443PubMedCrossRef
34.
go back to reference Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N (1995) In vivo glucosamine infusion induces insulin resistance in normoglycaemic but not in hyperglycaemic conscious rats. J Clin Invest 96:132–140PubMedCrossRef Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N (1995) In vivo glucosamine infusion induces insulin resistance in normoglycaemic but not in hyperglycaemic conscious rats. J Clin Invest 96:132–140PubMedCrossRef
35.
go back to reference Hawkins M, Barzilai N, Hu M, Chen W, Rossetti L (1997) Role of glucosamine pathway in fat-induced insulin resistance. J Clin Invest 99:2173–2183PubMedCrossRef Hawkins M, Barzilai N, Hu M, Chen W, Rossetti L (1997) Role of glucosamine pathway in fat-induced insulin resistance. J Clin Invest 99:2173–2183PubMedCrossRef
36.
37.
go back to reference Hart GW (1997) Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem 66:315–335PubMedCrossRef Hart GW (1997) Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem 66:315–335PubMedCrossRef
38.
go back to reference Balkan B, Dunning BE (1994) Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats. Diabetes 43:1173–1179PubMedCrossRef Balkan B, Dunning BE (1994) Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats. Diabetes 43:1173–1179PubMedCrossRef
39.
go back to reference Tang J, Neidigh JL, Cooksey RC, McClain DA (2000) Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. Diabetes 49:1492–1499PubMedCrossRef Tang J, Neidigh JL, Cooksey RC, McClain DA (2000) Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. Diabetes 49:1492–1499PubMedCrossRef
40.
go back to reference Marshall S, Bacote V, Traxinger R (1991) Discovery of a metabolic pathway mediating desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706–4712PubMed Marshall S, Bacote V, Traxinger R (1991) Discovery of a metabolic pathway mediating desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706–4712PubMed
41.
go back to reference Kaneto H, Kajimoto Y, Miyagawa J et al (1999) Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48:2398–2406PubMedCrossRef Kaneto H, Kajimoto Y, Miyagawa J et al (1999) Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48:2398–2406PubMedCrossRef
42.
go back to reference Ihara Y, Toyokuni S, Uchida K et al (1999) Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48:927–932PubMedCrossRef Ihara Y, Toyokuni S, Uchida K et al (1999) Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48:927–932PubMedCrossRef
43.
go back to reference Tiedge M, Lortz S, Munday R, Lenzen S (1999) Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 42:849–855PubMedCrossRef Tiedge M, Lortz S, Munday R, Lenzen S (1999) Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 42:849–855PubMedCrossRef
44.
go back to reference Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 96:10857–10862PubMedCrossRef Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 96:10857–10862PubMedCrossRef
45.
go back to reference Takahashi H, Tran PO, LeRoy E, Harmon JS, Tanaka Y, Robertson RP (2004) d-glyceraldehyde causes production of intracellular peroxide in pancreatic islets, oxidative stress, and defective beta cell function via non-mitochondrial pathways. J Biol Chem 279:37316–37323PubMedCrossRef Takahashi H, Tran PO, LeRoy E, Harmon JS, Tanaka Y, Robertson RP (2004) d-glyceraldehyde causes production of intracellular peroxide in pancreatic islets, oxidative stress, and defective beta cell function via non-mitochondrial pathways. J Biol Chem 279:37316–37323PubMedCrossRef
46.
go back to reference Lortz S, Gurgul-Convey E, Lenzen S, Tiedge M (2005) Importance of mitochondrial superoxide dismutase expression in insulin-producing cells for the toxicity of reactive oxygen species and proinflammatory cytokines. Diabetologia 48:1541–1548PubMedCrossRef Lortz S, Gurgul-Convey E, Lenzen S, Tiedge M (2005) Importance of mitochondrial superoxide dismutase expression in insulin-producing cells for the toxicity of reactive oxygen species and proinflammatory cytokines. Diabetologia 48:1541–1548PubMedCrossRef
47.
go back to reference Gurgul E, Lortz S, Tiedge M, Jorns A, Lenzen S (2004) Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines. Diabetes 53:2271–2280PubMedCrossRef Gurgul E, Lortz S, Tiedge M, Jorns A, Lenzen S (2004) Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines. Diabetes 53:2271–2280PubMedCrossRef
48.
go back to reference Gardner R, Salvador A, Moradas-Ferreira P (2002) Why does SOD overexpression sometimes enhance, sometimes decrease, hydrogen peroxide production? A minimalist explanation. Free Radic Biol Med 32:1351–1357PubMedCrossRef Gardner R, Salvador A, Moradas-Ferreira P (2002) Why does SOD overexpression sometimes enhance, sometimes decrease, hydrogen peroxide production? A minimalist explanation. Free Radic Biol Med 32:1351–1357PubMedCrossRef
49.
go back to reference Lortz S, Tiedge M (2003) Sequential inactivation of reactive oxygen species by combined overexpression of SOD isoforms and catalase in insulin-producing cells. Free Radic Biol Med 34:683–688PubMedCrossRef Lortz S, Tiedge M (2003) Sequential inactivation of reactive oxygen species by combined overexpression of SOD isoforms and catalase in insulin-producing cells. Free Radic Biol Med 34:683–688PubMedCrossRef
50.
go back to reference Fridlyand LE, Philipson LH (2004) Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic beta-cells? Diabetes 53:1942–1948PubMedCrossRef Fridlyand LE, Philipson LH (2004) Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic beta-cells? Diabetes 53:1942–1948PubMedCrossRef
Metadata
Title
The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets
Authors
S. Zraika
K. Aston-Mourney
D. R. Laybutt
M. Kebede
M. E. Dunlop
J. Proietto
S. Andrikopoulos
Publication date
01-06-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0212-9

Other articles of this Issue 6/2006

Diabetologia 6/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.